Up a level |
(2021) Safety and efficacy of Favipiravir in moderate to severe SARS-CoV-2 pneumonia. International Immunopharmacology. p. 8. ISSN 1567-5769
(2021) The efficacy of corticosteroids therapy in patients with moderate to severe SARS-CoV-2 infection: a multicenter, randomized, open-label trial. Respiratory Research. p. 14.
(2020) Real Clinical Practice and Therapeutic Management Following COVID-19 Crisis in two Hospitals in Iran: A Statistical and Conceptual View. Tanaffos. pp. 112-121. ISSN 1735-0344 (Print) 1735-0344
(2020) The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study. Daru-Journal of Pharmaceutical Sciences. pp. 507-516.